Waltham, MA, United States of America

Mukesh Mayani

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Bioverativ Therapeutics Inc., Fondazione Telethon, Ospedale San Raffaele S.r.l.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mukesh Mayani. Retrieved from https://idiyas.com/inventor/mukesh-mayani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mukesh Mayani: Innovator in Viral Vector Purification

Introduction

Mukesh Mayani is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of viral vector purification. His work has implications for gene therapy and vaccine development.

Latest Patents

Mukesh Mayani holds 1 patent for his invention titled "Methods for the purification of viral vectors." This patent outlines processes and methods for purifying a viral vector from a host cell, which is crucial for the production of effective viral vectors used in various therapeutic applications.

Career Highlights

Throughout his career, Mukesh has worked with prominent organizations such as Bioverativ Therapeutics Inc. and Fondazione Telethon. His experience in these companies has allowed him to develop and refine his expertise in viral vector production and purification.

Collaborations

Mukesh has collaborated with talented individuals in his field, including Tongyao Liu and Ayman Ismail. These partnerships have contributed to the advancement of his research and innovations.

Conclusion

Mukesh Mayani's work in viral vector purification represents a significant advancement in biotechnology. His contributions are vital for the ongoing development of gene therapies and vaccines, showcasing the importance of innovation in this field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…